首页 › 非小细胞肺癌 › 佛罗里达州

佛罗里达州的非小细胞肺癌临床试验

佛罗里达州有 164 项针对非小细胞肺癌的研究正在招募参与者。

佛罗里达州的城市

官方研究文本（英文）

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Boca Raton Clinical Research Coral Springs, Coral Springs
Regis Clinical Research LLC, Miami
Florida Clinical Trials Group Tamarac, Tamarac

招募中3 期

18 至 100 岁 · 所有性别 · 更新于 2026年11月13日 · NCT05920356

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Miami Cancer Institute, Miami

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年11月13日 · NCT07488676

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

BRCR Global - Coral Springs, Coral Springs
BRCR Global- Tamarac, Tamarac
Moffit Cancer Centre, Tampa

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年11月13日 · NCT07659782

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Moffit Cancer Center, Tampa

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年11月13日 · NCT07111520

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Local Institution - 0142, Pembroke Pines

招募中2/3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT07100080

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

The Oncology Institute of Hope and Innovation ( Site 0161), Fort Lauderdale

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT07190248

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Mid Florida Hematology and Oncology Center, Orange City
BRCR Global, Plantation

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06758401

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Morton Plant Hospital, Clearwater
Miami Cancer Institute, Miami
South Florida Baptist Hospital, Plant City
以及另外 6 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
Holy Cross Hospital, Fort Lauderdale
Regional Cancer Center-Lee Memorial Health System, Fort Myers
以及另外 6 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT04267848

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Cancer Specialists of North Florida - Fleming Island, Fleming Island
Cancer Specialists of North Florida - Riverside, Jacksonville
Cancer Specialists of North Florida Southside, Jacksonville
以及另外 6 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06472245

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

Holy Cross Hospital-Fort Lauderdale-57892, Fort Lauderdale

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT04886804

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Sarah Cannon Research Institute at Florida Cancer Specialists- Lake Nona, Orlando

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年11月12日 · NCT06914128

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Mayo Clinic in Florida ( Site 0014), Jacksonville
Mount Sinai Cancer Center ( Site 0038), Miami Beach
Mid Florida Hematology and Oncology Center ( Site 0018), Orange City

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月10日 · NCT06312137

A Study of DS-3939a in Participants With Solid Tumors

Moffitt Cancer Center - Magnolia Campus, Tampa

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年11月10日 · NCT07739966

A Study to Assess the Efficacy of WSD0922-FU in Patients With C797S+ Advanced Non-small Cell Lung Cancer

Cleveland Clinic Weston Hospital, Weston

招募中2 期

18 岁及以上 · 所有性别 · 更新于 2026年11月10日 · NCT06868485

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

AdventHealth Celebration, Celebration
Florida Clinical Trials Group, Plantation
Florida Cancer Specialists, Sarasota

招募中1 期

18 岁及以上 · 所有性别 · 更新于 2026年11月10日 · NCT07503808

Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)

Local Institution - 0527, Fort Myers
Local Institution - 0366, Orlando
Cancer Care Centers of Brevard - Rockledge, Palm Bay
以及另外 2 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月10日 · NCT07680790

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Fort Myers
Research Site, Jacksonville
Research Site, St. Petersburg
以及另外 2 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月10日 · NCT07291037

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Baptist MD Anderson Cancer Center, Baptist Health, Jacksonville
Florida Cancer Affiliates - Ocala Oncology, Ocala
Moffitt Cancer Center, Tampa

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月10日 · NCT06216301

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

The Oncology Institute of Hope and Innovation - Fort Lauderdale ( Site 0156), Fort Lauderdale
Miami Cancer Institute at Baptist Health, Inc. ( Site 0214), Miami

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月9日 · NCT06623422

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

UF Health Cancer Center ( Site 3257), Gainesville

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月9日 · NCT07513376

A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)

Bay Pines VA Healthcare System, Bay Pines

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月9日 · NCT07541170

A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%

Florida Cancer Specialists - North, St. Petersburg
Florida Clinical Trials Group., Tamarac
Florida Cancer Specialists - East, West Palm Beach

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月9日 · NCT06561386

A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

Baptist Health - Boca Raton Regional Hospital, Boca Raton

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月9日 · NCT07566052

A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Florida Cancer Specalists, Sarasota
Moffitt Cancer Center, Tampa

招募中1 期

18 至 99 岁 · 所有性别 · 更新于 2026年11月6日 · NCT06983743

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Clermont Oncology Center, Clermont
Mid Florida Hematology and Oncology Center, Orange City

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年11月6日 · NCT04198766

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Cancer Care Centers of Brevard, Inc., Palm Bay
Florida Cancer Affiliates - Panama City, Panama City

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月5日 · NCT07144280

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Florida Cancer Specialists - SOUTH - SCRI - PPDS, Fort Myers
University of Florida Health at Shands, Gainesville
BioResearch Partner, Hialeah
以及另外 6 项

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月5日 · NCT06793215

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation

Florida Cancer Specialists - SOUTH - SCRI - PPDS, Fort Myers
Florida Cancer Specialists - NORTH - SCRI - PPDS, St. Petersburg
Florida Cancer Specialists - EAST - SCRI - PPDS, West Palm Beach

招募中1/2 期

18 岁及以上 · 所有性别 · 更新于 2026年11月5日 · NCT05789082

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Local Institution - 0711, Ocala
Florida Clinical Trials Group, Tamarac

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月5日 · NCT07361497

Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC

Helios CR, Inc. - The Oncology Institute of Hope and Innovation - Fort Lauderdale, Fort Lauderdale
Florida Clinical Trials Group, LLC, Plantation
Florida Clinical Trials Group, Plantation

招募中3 期

18 岁及以上 · 所有性别 · 更新于 2026年11月4日 · NCT07777822